Background
==========

Now that the sequence of the human genome is almost complete, the research interest in genomics has moved from determining the sequence to the analysis of genetic variations, e.g. the Human Variome Project \[[@B1]\], and collecting data in locus-specific mutation databases \[[@B2],[@B3]\]. There is also a race to develop methods for cost-effective sequencing of the genomes of individuals \[[@B4]\]. Missense mutations in coding DNA, which lead to single amino acid changes in proteins, are commonly linked to human disorders \[[@B5]\]. The number of documented disease-linked missense and nonsense mutations is close to 30,000 \[[@B6]\]. A disease phenotype can arise because an amino acid change results in the loss of a critical protein function, in structural alterations, or because the mutation leads to \"gain of function\" effects such as functional dysregulation or the formation of toxic aggregates \[[@B7]-[@B9]\].

Only correctly folded proteins can deliver all the functional properties of a protein. Even minor changes in the size or properties of an amino acid side chain can alter or prevent the function of the protein. On the other hand, even large deletions or insertions may be tolerated in numerous positions within a protein \[[@B10]\]. The effects of mutations are also dependent on the protein sequence and structure context of the alteration. General statistical analyses have been performed for disease-causing mutations, for non-synonymous SNPs (nsSNPs) \[[@B9],[@B11]-[@B16]\], for groups of diseases, such as immunodeficiencies \[[@B3]\], and for groups of proteins, such as protein kinases \[[@B17]\]. Based on these studies and others, a number of methods have been developed for the prediction of tolerance and the consequences of mutations \[[@B13],[@B18]-[@B23]\].

Structural information is needed to fully understand the effects and consequences of mutations, whether disease-causing or used purposefully to modify the properties of a protein e.g. in protein engineering. Three-dimensional structures and computer models have been used by us and others to elucidate disease mechanisms from amino acid substitutions e.g. in references \[[@B24]-[@B26]\]. We have reviewed and discussed the applicability of more than 30 sequence and structure utilizing methods to predict the outcome of missense mutations to explain the basis of diseases \[[@B27]\]. Activity modifying mutations are also valuable for understanding the functions and conservation of amino acids and sequence regions in protein families. Recently, all the possible amino acid substitutions and their effects on biophysical properties were investigated in five proteins \[[@B28]\].

Secondary structural elements, α-helices, β-strands, turns and bends, are basic structural components of protein scaffolds. Amino acids are differently distributed between these elements. This information has been utilized for decades to predict the location of secondary structures from sequence information e.g. in references \[[@B29]-[@B34]\]. Secondary structures are common regular conformations of polypeptides, and they are the most energetically favourable structures. Each secondary structure type has characteristic backbone φ and ψ angles. Secondary structures fold together in proteins and form higher order structures such as super secondary structures, motifs, domains and tertiary structures. The organization of the folds is very similar in related protein structures even though the sequence identities can be very small. Secondary structures are generally of substantial length and can pass through the hydrophobic core of globular proteins. Within protein families the secondary structures are more conserved than the surface loops connecting the adjacent elements.

Since secondary structures are structural building blocks that cover some 25 -- 75% of the length of proteins, it would be interesting to know how disease-related, and thus function and/or structure altering, mutations affect these elements. We investigated the occurrence, location and distribution of disease-causing mutations in secondary structures. The study is based on statistics and bioinformatical analysis of three-dimensional structures and protein sequence information. Not many differences occur in mutation types between secondary structure elements and whole proteins. Clear differences were observed within the mutation spectra for different secondary structural elements and regions outside secondary structures. Some features, like the overrepresentation of arginines, were evident in all the secondary structures. Our analysis covers different amino acid substitutions, alterations of physicochemical properties, and sequence conservation. We investigated mutations both in the mutated original residues and in the mutant, altered, amino acids.

Results and discussion
======================

Secondary structures have an energetically favourable organization of the polypeptide chain. Our aim was to obtain a comprehensive map of the differences in mutation frequencies, location, contact energies and changes in residue volume and charge, both in the mutated amino acids and in the mutant amino acids, for the different secondary structure types. We collected information for 44 proteins involved in a large number of diseases (Table [1](#T1){ref-type="table"}). The criteria for choosing the proteins were a relatively large number of reported missense mutations and the availability of the three-dimensional structure. The genes in Table [1](#T1){ref-type="table"} are listed with the recommended HGNC names (HUGO Gene Nomenclature Committee) \[[@B35],[@B36]\]. The number of missense mutations varied from 8 to 240 per investigated protein or domain. The proteins represent different activities and functions including enzymes, signalling proteins, membrane proteins, receptors etc. 42 of the total of 46 structures had a resolution greater than 2.00 Å. There are more PDB entries than proteins because for the large BTK and VDR proteins there are two structures for different domains. The studied proteins contained altogether 2413 mutations of which 1935 (80%) appeared in secondary structures. The amino acid composition of all the proteins is in Figure [1](#F1){ref-type="fig"}. Considering the large size of the dataset and diversity of protein types and functions the statistically significant results reveal the true nature of disease-causing amino acid changes. In the χ^2^-test, results were considered significant with a *P*value \< 0.05.

###### 

Summary of analysed proteins and diseases

  Name                                                                                                                             Symbol   PDB          OMIM     Disease(s)                                                                                                                                                                                                                                                                                                                                                                                                    Mutations
  -------------------------------------------------------------------------------------------------------------------------------- -------- ------------ -------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  ABO blood group (transferase A, α1--3-N-acetylgalactosaminyltransferase; transferase B, α1--3-galactosyltransferase)             ABO      1lzj         110300   Blood group variation                                                                                                                                                                                                                                                                                                                                                                                         22
  alanine-glyoxylate aminotransferase (oxalosis I; hyperoxaluria I; glycolicaciduria; serine-pyruvate aminotransferase)            AGXT     1h0c         604285   Hyperoxaluria                                                                                                                                                                                                                                                                                                                                                                                                 22
  arylsulfatase B                                                                                                                  ARSB     1fsu         253200   Mucopolysaccharidosis VI                                                                                                                                                                                                                                                                                                                                                                                      30
  argininosuccinate lyase                                                                                                          ASL      1k62         608310   Argininosuccinate lyase deficiency                                                                                                                                                                                                                                                                                                                                                                            21
  Bruton agammaglobulinemia tyrosine kinase                                                                                        BTK      1btk, 1k2p   300300   X-linked agammaglobulinaemia                                                                                                                                                                                                                                                                                                                                                                                  144
  cystathionine-β-synthase                                                                                                         CBS      1jbq         236200   Homocystinuria                                                                                                                                                                                                                                                                                                                                                                                                74
  CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome)                                                                      CD40LG   1aly         300386   Hyper-IgM syndrome                                                                                                                                                                                                                                                                                                                                                                                            27
  cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7)                               CFTR     1xmj         602421   Asthma; Cystic fibrosis; Idiopathic pancreatitis; Congenital absence of vas deferens; Hereditary pancreatitis; Hypertrypsinaemia; Primary sclerosing cholangitis; Susceptibility to sarcoidosis; Idiopathic Bronchiectasis                                                                                                                                                                                    86
  CHK2 checkpoint homolog                                                                                                          CHEK2    1gxc         604373   Multiple cancers                                                                                                                                                                                                                                                                                                                                                                                              10
  doublecortex; lissencephaly, X-linked (doublecortin)                                                                             DCX      1mjd         300121   Double cortex syndrome; X linked lissencephaly syndrome; Subcortical band heterotopia; Resistant partial seizures                                                                                                                                                                                                                                                                                             16
  cytochrome b5 reductase 3                                                                                                        CYB5R3   1umk         250800   Methaemoglobinaemia                                                                                                                                                                                                                                                                                                                                                                                           18
  ectodysplasin A                                                                                                                  EDA      1rj7         300451   Ectodermal dysplasia                                                                                                                                                                                                                                                                                                                                                                                          22
  coagulation factor XIII, A1 polypeptide                                                                                          F13A1    1f13         134570   Factor XIII deficiency                                                                                                                                                                                                                                                                                                                                                                                        30
  coagulation factor VIII, procoagulant component (hemophilia A)                                                                   F8       1iqd         306700   Haemophilia A                                                                                                                                                                                                                                                                                                                                                                                                 39
  glucose-6-phosphate dehydrogenase                                                                                                G6PD     1qki         305900   Glucose-6-phosphate dehydrogenase deficiency                                                                                                                                                                                                                                                                                                                                                                  130
  GTP cyclohydrolase 1 (dopa-responsive dystonia)                                                                                  GCH1     1fb1         600225   Dopa-responsive and progressive dystonia; Tetrahydrobiopterin deficiency                                                                                                                                                                                                                                                                                                                                      45
  galactosidase, α                                                                                                                 GLA      1r46         301500   Fabry disease                                                                                                                                                                                                                                                                                                                                                                                                 179
  glucuronidase, β                                                                                                                 GUSB     1bhg         253220   Mucopolysaccharidosis VII; Hydrops fetalis                                                                                                                                                                                                                                                                                                                                                                    28
  hemoglobin, β                                                                                                                    HBB      1o1p         141900   Haemoglobin variant; Haemolytic anaemia; β-thalassaemia; Erythrocytosis; Sickle cell anaemia                                                                                                                                                                                                                                                                                                                  160
  homogentisate 1,2-dioxygenase (homogentisate oxidase)                                                                            HGD      1eyb         607474   Alkaptonuria                                                                                                                                                                                                                                                                                                                                                                                                  29
  hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome)                                                                  HPRT1    1bzy         308000   Hypoxanthine guanine phosphoribosyltransferase deficiency; Lesch-Nyhan syndrome; Hyperuricaemia; Hyperuricaemia with neurologic symptoms                                                                                                                                                                                                                                                                      105
  insulin receptor                                                                                                                 INSR     1ir3         147670   Leprechaunism; Insulin resistance; Insulin resistance A; Association with reduced diastolic blood pressure; Diabetes, NIDDM; Rabson-Mendenhall syndrome                                                                                                                                                                                                                                                       19
  lamin A/C                                                                                                                        LMNA     1ifr         150330   Muscular dystrophy; Emery-Dreifuss; Seip syndrome; Dilated cardiomyopathy; Partial lipodystrophy; Atypical Werner Syndrome; Familial autosomal dominant partial lipodystrophy (Dunnigan variety); Hutchinson-Gilford progeria syndrome; Charcot-Marie-Tooth disease 2; Cardiac conduction defects; Muscular dystrophy; Partial lipodystrophy; Mandibuloacral dysplasia; Association with metabolic syndrome   22
  neurofibromin 2 (bilateral acoustic neuroma)                                                                                     NF2      1h4r         607379   Neurofibromatosis 2                                                                                                                                                                                                                                                                                                                                                                                           8
  ornithine aminotransferase (gyrate atrophy)                                                                                      OAT      2oat         258870   Gyrate atrophy                                                                                                                                                                                                                                                                                                                                                                                                27
  ornithine carbamoyltransferase                                                                                                   OTC      1oth         300461   Ornithine transcarbamylase deficiency; Hyperammonaemia                                                                                                                                                                                                                                                                                                                                                        154
  phenylalanine hydroxylase                                                                                                        PAH      1j8u         261600   Phenylketonuria; Hyperphenylalaninaemia                                                                                                                                                                                                                                                                                                                                                                       240
  paired box gene 6 (aniridia, keratitis)                                                                                          PAX6     6pax         607108   Aniridia; Congenital cataract; Peters\' anomaly; Optic-nerve malformations; Congenital nystagmus; Ectopia pupillae; Isolated foveal hypoplasia; Ocular anterior segment anomaly                                                                                                                                                                                                                               27
  pyruvate dehydrogenase (lipoamide) α1                                                                                            PDHA1    1ni4         300502   Pyruvate dehydrogenase deficiency; Lactic acidosis; Leigh syndrome                                                                                                                                                                                                                                                                                                                                            40
  pyruvate kinase, liver and RBC                                                                                                   PKLR     1liu         266200   Elevated red cell ATP; Haemolytic anaemia; Pyruvate kinase deficiency                                                                                                                                                                                                                                                                                                                                         93
  prion protein (p27--30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)             PRNP     1i4m         176640   Gerstmann-Straussler-Scheinker syndrome; Dementia; Creutzfeld-Jakob syndrome; Schizophrenia; Familial spongiform encephalopathy; Fatal familial insomnia; Prion disease                                                                                                                                                                                                                                       23
  retinoblastoma 1 (including osteosarcoma)                                                                                        RB1      1gux         180200   Retinoblastoma                                                                                                                                                                                                                                                                                                                                                                                                18
  solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)                      SLC4A1   1hyn         109270   Spherocytosis; Blood group variation; Erythrocyte band 3 deficiency; Anaemia; Distal renal tubular acidosis; Acanthocytosis                                                                                                                                                                                                                                                                                   7
  superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))                                                        SOD1     1mfm         147450   Amyotrophic lateral sclerosis; Motor neuron disease                                                                                                                                                                                                                                                                                                                                                           69
  sex determining region Y                                                                                                         SRY      1j46         480000   XY sex reversal; Gonadal dysgenesis; Hermaphroditism                                                                                                                                                                                                                                                                                                                                                          31
  transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor                                   TCF1     1ic8         142410   Diabetes mellitus, type 2; MODY; MODY2; MODY3; Serum C-peptide and insulin response; Insulin resistance                                                                                                                                                                                                                                                                                                       40
  thyroid hormone receptor, β thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)   THRB     1nq2         190160   Thyroid hormone resistance                                                                                                                                                                                                                                                                                                                                                                                    72
  troponin T type 2 (cardiac)                                                                                                      TNNT2    1j1d         191045   hypertrophic/dilated cardiomyopathy                                                                                                                                                                                                                                                                                                                                                                           4
  troponin I type 3 (cardiac)                                                                                                      TNNI3    1j1e         191044   hypertrophic/restrictive cardiomyopathy                                                                                                                                                                                                                                                                                                                                                                       7
  tumor protein p53 (Li-Fraumeni syndrome)                                                                                         TP53     1tup         191170   Li-Fraumeni syndrome; Adrenocortical carcinoma; Sarcoma; Lung cancer; Breast cancer; Carcinoma; Glioma; Astrocytoma; Adrenocortical carcinoma; Glioblastoma; Cytosarcoma phyllodes; Osteosarcoma; Multiple cancers; Familial adenomatous polyposis; Rhabdomyosarcoma; Ependymoma; Adenocarcinoma; Thyroid tumour; Leukaemia/lymphoma; Neuroblastoma                                                           73
  uroporphyrinogen decarboxylase                                                                                                   UROD     1r3s         176100   Porphyria cutanea tarda; Hepatoerythropoietic porphyria                                                                                                                                                                                                                                                                                                                                                       37
  uroporphyrinogen III synthase (congenital erythropoietic porphyria)                                                              UROS     1jr2         606938   Erythropoietic porphyria; Guenther disease                                                                                                                                                                                                                                                                                                                                                                    21
  vitamin D (1,25-dihydroxyvitamin D3) receptor                                                                                    VDR      1ie9, 1kb2   601769   Higher bone mineral density; Rickets                                                                                                                                                                                                                                                                                                                                                                          10
  von Hippel-Lindau tumor suppressor                                                                                               VHL      1lm8         608537   von Hippel-Lindau syndrome; Phaeochromocytoma; Haemangioblastoma; Pancreatic cancer; Polycythemia, with high erythropoietin concentration; Phaeochromocytoma and paraganglioma                                                                                                                                                                                                                                134

![**Amino acid distribution and relative mutability**. Top row. Amino acid distribution in the investigated proteins (left), overall relative mutability of mutated (middle) and mutant residues (right). The same information is on the second row only for α-helices, third row for β-strands, fourth row for turns and bends, and in the bottom row for structures outside secondary structural elements.](1472-6807-7-56-1){#F1}

The total chain length of the 44 investigated proteins is 12540 amino acids. The secondary structure elements consist as follows: all helix structures altogether 4567 amino acids of which α-helices 4118 (\~90%), 3~10~-helices 449 (\~10%) and π-helices just 2 residues. There are 153 amino acids in β-bridges and 2530 in β-ladders, altogether 2683 (27%), and there are 1436 (15%) and 1190 (12%) residues in turns and bends, respectively. 18 proteins belong to SCOP \[[@B37]\] class for all-α proteins, 12 proteins belong to all-β proteins, 22 proteins belong to α and β proteins (14 α/β and 8 α+β) and 2 to coiled coil proteins. Btk PH domain belongs to all-β proteins and kinase domain to α+β proteins. In VDR, nuclear receptor ligand-binding domain belongs to all-α proteins and glucocorticoid receptor-like (DNA-binding domain) to SCOP class for small proteins. Altogether there were 1939 mutations in the secondary structures, 48% in helices, 28% in β-structures, and 24% in turns and bends. These numbers follow the distribution of the structure elements. The length of the secondary structures varied as follows: α-helices from 1 to 46 residues, average length being 11.3 residues, 3~10~-helices from 2 to 9 residues, average 3.4. In β-strands the length varied from 1 to 22, average 5.28. Length of the structure in turns varied from 1 to 8 residues, average 2.1, and in bends from 1 to 6, average 1.6.

Overall amino acid mutational spectrum
--------------------------------------

Table [2](#T2){ref-type="table"} summarizes all the mutations in the studied proteins and Table [3](#T3){ref-type="table"} mutations in the secondary structures only. DSSP classifies secondary structures into three helix types, two extended β-strand types, turns and bends. The helices represent the classical α-helix, π-helix and 3~10~-helix. The difference between the helix types originates from the number of residues per turn. In the normal right-handed α-helix there are 3.6 residues per turn, while π-helix has 4.4, and 3~10~-helix only three. In helical structures the main chain residues form stabilizing hydrogen bonds with residues further in the sequence. All the side chains are pointing out from the helical core. A large proportion of α-helices are amphipathic i.e. one face of the helix is hydrophilic and the other hydrophobic \[[@B38]\]. The 3~10~-helix is the fourth most common type of secondary structure in proteins after α-helices, β-strands, and reverse turns \[[@B39]\]. 3~10~-helices commonly appear as N- or C-terminal extensions of α-helices. They are typically only three residues long compared with a mean of 10--12 residues for α-helices \[[@B40]\]. β-Strands are divided into isolated β-bridges and extended strands. β-Strands can form structure stabilizing hydrogen bonds only with another strand in a parallel or antiparallel manner. Bends and turns are, according to DSSP terminology, relatively short structures that are located between the helical and strand elements. Well organized β- and γ-turns reverse the direction of the polypeptide chain. Only glycines are allowed in certain turns at certain positions due to steric restrictions in very tight bends.

###### 

Spectrum of mutations in all residues in the studied proteins^a^

  Amino acid   Original residues   Expected residues   χ^2^               *P*value   Mutant residues   Expected residues   χ^2^              *P*value
  ------------ ------------------- ------------------- ------------------ ---------- ----------------- ------------------- ----------------- ----------
  A            169                 161                 0.43               5.14E-01   83                148                 *28.28\*\*\**     1.05E-07
  C            79                  38                  **43.38\*\*\***    4.51E-11   133               86                  **25.54\*\*\***   4.34E-07
  D            98                  131                 *8.28\*\**         4.00E-03   155               98                  **32.54\*\*\***   1.16E-08
  E            113                 168                 *17.82\*\*\**      2.43E-05   84                86                  0.05              8.20E-01
  F            66                  104                 *13.66\*\*\**      2.19E-04   90                98                  0.72              3.97E-01
  G            246                 167                 **37.28\*\*\***    1.02E-09   106               141                 *8.89\*\**        2.87E-03
  H            87                  61                  **10.74\*\*\***    1.05E-03   108               98                  0.93              3.34E-01
  I            99                  126                 *5.76\**           1.64E-02   80                129                 *18.71\*\*\**     1.52E-05
  K            56                  140                 *50.05\*\*\**      1.50E-12   109               86                  **6.09\***        1.36E-02
  L            231                 239                 0.29               5.89E-01   113               203                 *39.88\*\*\**     2.70E-10
  M            78                  58                  **7.00\*\***       8.15E-03   97                55                  **31.33\*\*\***   2.18E-08
  N            90                  92                  0.03               8.58E-01   74                98                  *6.05\*\**        1.39E-02
  P            94                  122                 *6.54\*\**         1.05E-02   194               148                 **14.58\*\*\***   1.35E-04
  Q            62                  102                 *15.50\*\*\**      8.24E-05   115               86                  **9.69\*\***      1.85E-03
  R            348                 142                 **299.39\*\*\***   4.48E-67   222               209                 0.79              3.73E-01
  S            125                 146                 2.95               8.58E-02   174               228                 *12.61\*\*\**     3.84E-04
  T            84                  123                 *12.50\*\*\**      4.08E-04   136               148                 0.91              3.39E-01
  V            147                 168                 2.73               9.88E-02   185               148                 **9.47\*\***      2.09E-03
  W            55                  37                  **9.34\*\***       2.24E-03   77                43                  **26.77\*\*\***   2.30E-07
  Y            84                  87                  0.11               7.40E-01   76                74                  0.07              7.98E-01
                                                                                                                                             
  Sum          2411                2411                                              2411              2411                                  

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

###### 

Spectrum of mutations appearing in α-helix, β-strand, turn and bend structures, expected values are calculated from mutated and mutant amino acid composition in the studied proteins^a^

  Amino acid   Original residues   Expected residues   χ^2^       *P*value   Mutant residues   Expected residues   χ^2^            *P*value
  ------------ ------------------- ------------------- ---------- ---------- ----------------- ------------------- --------------- ----------
  A            148                 136                 1.07       3.00E-01   58                67                  1.15            2.84E-01
  C            54                  64                  1.43       2.32E-01   117               107                 0.94            3.32E-01
  D            81                  79                  0.06       8.06E-01   112               125                 1.28            2.57E-01
  E            96                  91                  0.29       5.91E-01   71                68                  0.18            6.75E-01
  F            53                  53                  0.00       9.91E-01   77                72                  0.29            5.87E-01
  G            220                 198                 2.48       1.15E-01   95                85                  1.12            2.91E-01
  H            63                  70                  0.69       4.05E-01   91                87                  0.20            6.57E-01
  I            83                  80                  0.14       7.05E-01   55                64                  1.36            2.44E-01
  K            43                  45                  0.09       7.61E-01   92                88                  0.21            6.43E-01
  L            188                 186                 0.03       8.70E-01   96                91                  0.29            5.91E-01
  M            65                  63                  0.08       7.74E-01   48                78                  *11.54\*\*\**   6.79E-04
  N            60                  72                  2.12       1.46E-01   61                60                  0.04            8.47E-01
  P            68                  76                  0.76       3.82E-01   170               156                 1.25            2.63E-01
  Q            45                  50                  0.47       4.91E-01   89                92                  0.13            7.17E-01
  R            299                 280                 1.31       2.53E-01   196               179                 1.71            1.91E-01
  S            78                  101                 *5.05\**   2.46E-02   144               140                 0.12            7.31E-01
  T            62                  68                  0.46       4.99E-01   119               109                 0.85            3.57E-01
  V            122                 118                 0.12       7.28E-01   138               149                 0.78            3.77E-01
  W            44                  44                  0.00       9.72E-01   56                62                  0.57            4.51E-01
  Y            67                  68                  0.00       9.46E-01   54                61                  0.83            3.62E-01
                                                                                                                                   
  Sum          1939                1939                                      1939              1939                                

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

First we investigated the statistical significance for mutated and mutant amino acids located in secondary structures compared to overall distribution. Then the patterns within each secondary structural element were revealed.

Arginine is clearly the most mutated residue type, as already indicated in previous studies \[[@B41]-[@B43]\]. The very high mutability of codons for arginine arises from CpG dinucleotides, which can spontaneously mutate by deamination either to TG or CA dinucleotides \[[@B44]\]. Arginine is coded by six codons, four of which have a CpG dinucleotide in the first and second codon position. In addition to the CpG dinucleotide we have also shown previously that the surrounding sequence context has an effect on mutability \[[@B42]\].

We calculated the relative mutability of all the amino acids as both mutant and mutated residues (Fig. [1](#F1){ref-type="fig"}). The residue that had the lowest ratio of observed vs. expected mutations (marked \'1\') was used as a reference in these calculations. This residue is lysine for mutated and alanine for mutant residues.

Among the original residues, arginine has clearly the highest relative mutability. The picture is completely different for the mutant residues, where the overall relative mutability among mutant residues is highest for cysteine and tryptophan. Table [2](#T2){ref-type="table"} shows that C, D, H, K, P and W are highly mutated residues. In the second place after arginine in mutated residues is cysteine. Glycine and tryptophan are also highly significantly overrepresented among mutated residues. Proline is the only amino acid forming a ring with the backbone and it has very rigid structure, which bends the main chain of the protein in a characteristic way. Proline is a known breaker of secondary structures \[[@B30]\]. K, E, Q, F and T are significantly underrepresented among mutated residues.

From Table [3](#T3){ref-type="table"} can be seen that the distribution of mutations in secondary structural elements is very close to that expected based on the mutation count in the whole proteins. Only S as mutated and M as mutant residue type are significantly underrepresented. Based on the amino acid distributions (Fig. [1](#F1){ref-type="fig"}) the composition of α-helices is close to the general distribution whereas β-structures and turns and bends have clearly different distribution. The amino acid compositions within secondary structures are very different. The share of α-helices is 36%, β-structures 21% and turns and bends 21% (remaining 21% is in areas not defined to any secondary structure type) of all the residues in the investigated structures. The secondary structures harbour 80% of all the disease-causing mutations. The amino acid distribution outside the regular secondary structural elements is very similar to whole protein except for high overrepresentation for P. The trends for mutated and mutant residues are similar to whole proteins. R has very high relative mutability for original residues (Fig. [1](#F1){ref-type="fig"}).

The only remarkable difference between Tables [2](#T2){ref-type="table"} and [4](#T4){ref-type="table"} (data calculated based on the amino acid distribution in secondary structures) is methionine, which is highly overrepresented in Table [2](#T2){ref-type="table"} for all the mutations as a mutant residue, but has no statistical correlation in the secondary structures (Table [4](#T4){ref-type="table"}). A, L and I appear much less frequently amongst the replacing residues than expected. Our results are in line with those published previously for general mutation distribution \[[@B11],[@B12]\].

###### 

Spectrum of mutations appearing in α-helix, β-strand, turn and bend structures. Expected values are calculated from amino acid composition in secondary structural elements^a^

  Amino acid   Original residues   Expected residues   χ^2^               *P*value   Mutant residues   Expected residues   χ^2^              *P*value
  ------------ ------------------- ------------------- ------------------ ---------- ----------------- ------------------- ----------------- ----------
  A            148                 139                 0,53               4.66E-01   58                119                 *31.05\*\*\**     2.51E-08
  C            54                  32                  **15,50\*\*\***    6.82E-05   117               69                  **32.93\*\*\***   9.58E-09
  D            81                  96                  2,34               1.26E-01   112               79                  **13.64\*\*\***   2.21E-04
  E            96                  147                 *17,60\*\*\**      2.71E-05   71                69                  0.04              8.33E-01
  F            53                  87                  *13,51\*\*\**      2.36E-04   77                79                  0.06              8.10E-01
  G            220                 136                 **52,47\*\*\***    4.48E-13   95                114                 3.10              7.85E-02
  H            63                  48                  **5,06\***         2.47E-02   91                79                  1.78              1.83E-01
  I            83                  110                 *6,51\*\**         1.07E-02   55                104                 *23.00\*\*\**     1.62E-06
  K            43                  113                 *43,42\*\*\**      4.37E-11   92                69                  **7.47\*\***      6.26E-03
  L            188                 205                 1,34               2.46E-01   96                163                 *27.69\*\*\**     1.42E-07
  M            65                  49                  **5,02\***         2.51E-02   48                45                  0.27              6.02E-01
  N            60                  69                  1,10               2.93E-01   61                79                  *4.16\**          4.14E-02
  P            68                  67                  0,02               8.98E-01   170               119                 **22.16\*\*\***   2.51E-06
  Q            45                  82                  *16,87\*\*\**      3.98E-05   89                69                  **5.63\***        1.76E-02
  R            299                 119                 **272,51\*\*\***   3.43E-61   196               168                 **4.60\***        3.19E-02
  S            78                  104                 *6,60\*\**         1.01E-02   144               183                 *8.32\*\**        3.92E-03
  T            62                  92                  *10,03\*\**        1.53E-03   119               119                 0.00              9.79E-01
  V            122                 144                 3,33               7.01E-02   138               119                 3.13              7.67E-02
  W            44                  30                  **6,27\*\***       1.23E-02   56                35                  **13.20\*\*\***   2.81E-04
  Y            67                  70                  0,15               6.95E-01   54                59                  0.48              4.87E-01
                                                                                                                                             
  Sum          1939                1939                                              1939              1939                                  

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

Mutational spectrum within α-helices, β-strands and turns and bends
-------------------------------------------------------------------

The amino acid composition in α-helices is very similar to overall amino acid composition (Fig. [1](#F1){ref-type="fig"}). The only main difference is in the ratio of glycines and prolines, which are clearly depleted in the helices, whereas glycines, as expected, are especially strongly overrepresented in turns and bends. The most prominent residues in β-strands are aliphatic isoleucine, leucine and valine followed by alanine, phenylalanine and threonine. Aspartic acid is surprisingly frequent in turns and bends.

In the analysis of helix mutations in all secondary structures \[see Additional file [1](#S1){ref-type="supplementary-material"}\] glycine is very significantly underrepresented as mutated residue and also A and N have statistically significant values. M is the only significant mutant residue type. Correspondingly V, I and S have significant chi square values as mutated residues in β-strand, S, V and W as mutated residues \[see Additional file [2](#S2){ref-type="supplementary-material"}\]. In turns and bends the significantly mutated amino acids are S, V, A, D, I, K and L and as mutant residues E, M, and R \[see Additional file [3](#S3){ref-type="supplementary-material"}\].

We further investigated the mutations within these secondary structures. The distribution of disease-causing mutations in helical structures in the investigated 44 structures is shown in Table [5](#T5){ref-type="table"}. The number of mutations in helices is altogether 928 (48%), whereas β-strand structures of extended strands and isolated β-bridges contain 550 (28%) missense mutations (Table [6](#T6){ref-type="table"}) and hydrogen bonded turns and bends contain 461 (24%) mutations (Table [7](#T7){ref-type="table"}). The results for original and mutant residues are clearly and significantly very different for the different structural elements. In helices, besides arginine and cysteine other residues are not very highly mutated. If only the secondary structures are taken into account, glycine appears to be the most mutated residue after arginine. This result is similar to a Steward et al. study that revealed that glycine was the second most frequently mutating amino acid in the OMIM disease database \[[@B9]\].

###### 

Spectrum of mutations in α-helices^a^

  Amino acid   Original residues   Expected residues   χ^2^               *P*value   Mutant residues   Expected residues   χ^2^              *P*value
  ------------ ------------------- ------------------- ------------------ ---------- ----------------- ------------------- ----------------- ----------
  A            89                  83                  0.45               5.03E-01   23                57                  *20.13\*\*\**     7.25E-06
  C            26                  14                  **11.27\*\*\***    7.88E-04   56                33                  **15.76\*\*\***   7.18E-05
  D            34                  44                  2.23               1.35E-01   59                38                  **11.78\*\*\***   5.99E-04
  E            61                  96                  *12.71\*\*\**      3.64E-04   26                33                  1.54              2.15E-01
  F            28                  36                  1.76               1.84E-01   37                38                  0.02              8.87E-01
  G            48                  30                  **10.69\*\*\***    1.08E-03   46                54                  1.31              2.52E-01
  H            23                  21                  0.13               7.19E-01   41                38                  0.26              6.12E-01
  I            41                  51                  1.96               1.61E-01   29                50                  *8.63\*\**        3.30E-03
  K            20                  61                  *27.70\*\*\**      1.41E-07   52                33                  **10.73\*\*\***   1.05E-03
  L            101                 112                 1.04               3.09E-01   49                78                  *10.86\*\*\**     9.85E-04
  M            41                  29                  **5.11\***         2.37E-02   24                21                  0.34              5.59E-01
  N            22                  27                  1.08               3.00E-01   29                38                  2.08              1.49E-01
  P            29                  24                  1.15               2.84E-01   90                57                  **19.38\*\*\***   1.07E-05
  Q            28                  45                  *6.12\**           1.34E-02   55                33                  **14.41\*\*\***   1.47E-04
  R            153                 64                  **122.78\*\*\***   1.56E-28   73                80                  0.70              4.04E-01
  S            36                  46                  2.22               1.36E-01   53                88                  *13.66\*\*\**     2.19E-04
  T            30                  38                  1.84               1.75E-01   61                57                  0.31              5.79E-01
  V            62                  59                  0.18               6.69E-01   69                57                  2.61              1.06E-01
  W            24                  16                  **4.19\***         4.06E-02   32                17                  **14.36\*\*\***   1.51E-04
  Y            32                  33                  0.01               9.29E-01   24                28                  0.68              4.08E-01
                                                                                                                                             
  Sum          928                 928                                               928               928                                   

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

###### 

Spectrum of mutations in β-strands^a^

  Amino acid   Original residues   Expected residues   χ^2^              *P*value   Mutant residues   Expected residues   χ^2^              *P*value
  ------------ ------------------- ------------------- ----------------- ---------- ----------------- ------------------- ----------------- ----------
  A            39                  33                  0.93              3.34E-01   14                34                  *11.49\*\*\**     6.98E-04
  C            19                  12                  **4.58\***        3.24E-02   39                20                  **19.08\*\*\***   1.26E-05
  D            17                  15                  0.22              6.38E-01   26                22                  0.56              4.54E-01
  E            21                  25                  0.64              4.23E-01   20                20                  0.01              9.36E-01
  F            15                  36                  *12.66\*\*\**     3.75E-04   24                22                  0.11              7.43E-01
  G            44                  27                  **10.61\*\*\***   1.13E-03   27                32                  0.86              3.54E-01
  H            23                  13                  **8.33\*\***      3.90E-03   32                22                  **4.06\***        4.38E-02
  I            34                  49                  *4.80\**          2.84E-02   16                29                  *6.15\*\**        1.31E-02
  K            13                  23                  *4.60\**          3.20E-02   23                20                  0.57              4.49E-01
  L            63                  66                  0.10              7.48E-01   27                46                  *8.05\*\**        4.56E-03
  M            14                  13                  0.03              8.53E-01   16                13                  0.90              3.43E-01
  N            19                  14                  1.67              1.97E-01   20                22                  0.27              6.05E-01
  P            15                  11                  1.08              2.99E-01   47                34                  **5.27\***        2.16E-02
  Q            10                  16                  2.24              1.34E-01   20                20                  0.01              9.36E-01
  R            77                  29                  **80.03\*\*\***   3.69E-19   60                48                  3.17              7.50E-02
  S            15                  23                  2.88              8.98E-02   55                52                  0.18              6.68E-01
  T            16                  35                  *10.20\*\*\**     1.41E-03   36                34                  0.16              6.88E-01
  V            53                  71                  *4.44\**          3.51E-02   27                34                  1.32              2.50E-01
  W            16                  10                  3.23              7.25E-02   8                 10                  0.34              5.61E-01
  Y            27                  27                  0.00              9.60E-01   13                17                  0.87              3.50E-01
                                                                                                                                            
  Sum          550                 550                                              550               550                                   

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

###### 

Spectrum of mutations in turns and bends^a^

  Amino acid   Original residues   Expected residues   χ^2^              *P*value   Mutant residues   Expected residues   χ^2^              *P*value
  ------------ ------------------- ------------------- ----------------- ---------- ----------------- ------------------- ----------------- ----------
  A            20                  24                  0.79              3.73E-01   21                28                  1.85              1.74E-01
  C            9                   7                   0.97              3.26E-01   22                16                  1.86              1.72E-01
  D            30                  35                  0.70              4.04E-01   27                19                  3.56              5.92E-02
  E            14                  27                  *6.28\*\**        1.22E-02   25                16                  **4.43\***        3.54E-02
  F            10                  16                  2.13              1.45E-01   16                19                  0.42              5.16E-01
  G            128                 72                  **43.23\*\*\***   4.87E-11   22                27                  0.94              3.32E-01
  H            17                  13                  1.12              2.91E-01   18                19                  0.04              8.51E-01
  I            8                   12                  1.20              2.73E-01   10                25                  *8.75\*\**        3.10E-03
  K            10                  28                  *11.80\*\*\**     5.92E-04   17                16                  0.02              8.95E-01
  L            24                  30                  1.27              2.60E-01   20                39                  *9.12\*\**        2.53E-03
  M            10                  8                   0.67              4.13E-01   8                 11                  0.63              4.27E-01
  N            19                  26                  1.72              1.90E-01   12                19                  2.47              1.16E-01
  P            24                  29                  1.02              3.12E-01   33                28                  0.81              3.69E-01
  Q            7                   21                  *9.71\*\**        1.84E-03   14                16                  0.37              5.44E-01
  R            69                  26                  **70.17\*\*\***   5.44E-17   63                40                  **13.25\*\*\***   2.73E-04
  S            27                  34                  1.27              2.59E-01   36                44                  1.30              2.55E-01
  T            16                  20                  0.68              4.09E-01   22                28                  1.37              2.41E-01
  V            7                   17                  *6.05\*\**        1.39E-02   42                28                  **6.72\*\***      9.52E-03
  W            4                   5                   0.07              7.92E-01   16                8                   **7.33\*\***      6.78E-03
  Y            8                   11                  1.02              3.13E-01   17                14                  0.59              4.42E-01
                                                                                                                                            
  Sum          461                 461                                              461               461                                   

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

In helices, lysine is a strongly underrepresented residue compared with the calculated expected value. P, C, Q, W and D show statistically significant overrepresentation when compared to expected values, while S and L are underrepresented among mutant amino acids. Relative mutability in α-helices indicates that arginine is 7.29 times more mutated than expected whereas glycine is 4.88 times so.

In β-structures, R is statistically very significantly overrepresented and G and H have weaker enrichment. T is the statistically least mutated residue in β-strands. Among mutant residues, C is highly overrepresented and A underrepresented. Otherwise the results are less biased than in helices.

R is also statistically the most overrepresented residue in turns and bends although the χ^2^score is smaller than for the other secondary structures. G is the only other statistically highly significantly overrepresented amino acid. G is the most flexible residue because it does not have a side chain. It often appears in tight turns where no other residue can replace it. K is highly underrepresented among the mutated residues. Interestingly, R is the most enriched amino acid among mutant residues.

The distributions of amino acid frequencies and relative mutabilities in the different structural elements (Fig. [1](#F1){ref-type="fig"}) are clearly very different. First of all, the values are higher for mutated residues than for mutant residues, indicating that the original residue in many instances is very important and substitutions to any other residue are not possible without detrimental effects. Arginine and glycine are among the most mutated residues in all secondary structures whereas the other amino acids have large variations between the secondary structure types. The effect of arginine can also be seen in the data for mutant residues. Point mutations in arginine lead mostly to cysteine and glutamine, which have relatively high mutability values. The mutant residues in turns and bends have a more even distribution than the other two elements because practically any mutation to key residues in a tight hairpin turn leads either to the loss of hydrogen bonds or does not allow tight turn formation and leads to consequent structural alterations.

The data for mutations outside regular elements (Table [8](#T8){ref-type="table"}) indicate that R, H and Y are significantly overrepresented and Q, K and E underrepresented among mutated residues while N is the only residue type that is significantly overrepresented.

###### 

Mutated and mutant residues not in secondary structures^a^

  Amino acid group   Original residues   Expected residues   χ^2^              P value    Mutant residues   Expected residues   χ^2^           P value
  ------------------ ------------------- ------------------- ----------------- ---------- ----------------- ------------------- -------------- ----------
  A                  18                  22                  0.84              3.58E-01   21                29                  2.16           1.42E-01
  C                  12                  7                   4.51              3.37E-02   25                17                  **3.93\***     4.73E-02
  D                  46                  34                  4.20              4.04E-02   17                19                  0.27           6.06E-01
  E                  10                  22                  *6.53\*\**        1.06E-02   17                17                  0.00           9.72E-01
  F                  15                  17                  0.17              6.83E-01   13                19                  2.04           1.53E-01
  G                  35                  32                  0.37              5.40E-01   26                28                  0.10           7.48E-01
  H                  27                  14                  **13.05\*\*\***   3.04E-04   24                19                  1.16           2.81E-01
  I                  19                  17                  0.23              6.32E-01   16                25                  3.41           6.48E-02
  K                  11                  27                  *9.15\*\**        2.49E-03   13                17                  0.88           3.47E-01
  L                  29                  36                  1.36              2.44E-01   43                40                  0.27           6.04E-01
  M                  6                   9                   0.93              3.36E-01   13                11                  0.43           5.11E-01
  N                  10                  23                  *6.96\*\**        8.34E-03   30                19                  **5.98\*\***   1.45E-02
  P                  61                  52                  1.44              2.29E-01   26                29                  0.29           5.90E-01
  Q                  3                   20                  *13.97\*\*\**     1.86E-04   17                17                  0.00           9.72E-01
  R                  53                  23                  **37.42\*\*\***   9.51E-10   49                41                  1.59           2.08E-01
  S                  31                  40                  2.13              1.45E-01   47                45                  0.13           7.14E-01
  T                  24                  30                  1.25              2.63E-01   22                29                  1.65           1.99E-01
  V                  25                  25                  0.00              9.44E-01   25                29                  0.53           4.68E-01
  W                  8                   6                   0.41              5.22E-01   11                8                   0.78           3.76E-01
  Y                  29                  17                  **8.77\*\***      3.06E-03   17                14                  0.45           5.02E-01
                                                                                                                                               
  Sum                472                 472                                              472               472                                

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

Mutational spectrum in amino acid groups within structural elements
-------------------------------------------------------------------

Amino acids can be grouped based on their physicochemical nature. The reason for performing an analysis with residue categories is that in many sites the specific amino acid is not very important but the suitable properties it provides is. This can be seen e.g. in multiple sequence alignments of protein families. We used the following six groups: hydrophobic (V, I, L, F, M, W, Y, C), positively charged (R, K, H), negatively charged (D and E), conformational (G and P), polar (N, Q, S) and (A and T) \[[@B45]\]. These groups follow the amino acid substitution matrices used for sequence alignments and database searches. The results for amino acid frequencies in the secondary structure types are in Tables [9](#T9){ref-type="table"}, [10](#T10){ref-type="table"}, [11](#T11){ref-type="table"}. Different groups are over- or underrepresented in different structure types. Negatively charged residues, due to arginine, are overrepresented in all three tables. Conformational residues are also overrepresented in all three secondary structure classes, but with varying χ^2^-values. Positively charged amino acids are significantly underrepresented in helices and overrepresented in turns and bends.

###### 

Spectrum of mutations in α-helices in amino acid groups^a^

  Amino acid group     Original residues   Expected residues   χ^2^              *P*value   Mutant residues   Expected residues   χ^2^         *P*value
  -------------------- ------------------- ------------------- ----------------- ---------- ----------------- ------------------- ------------ ----------
  Hydrophobic          355                 348                 0.13              7.19E-01   320               322                 0.01         9.13E-01
  Positively charged   95                  140                 *14.36\*\*\**     1.51E-04   85                71                  2.75         9.71E-02
  Negatively charged   196                 147                 **16.56\*\*\***   4.71E-05   166               152                 1.39         2.39E-01
  Conformational       77                  54                  **9.96\*\***      1.60E-03   136               111                 **5.50\***   1.90E-02
  Polar                86                  118                 *8.70\*\**        3.17E-03   137               159                 2.94         8.62E-02
  A+T                  119                 121                 0.04              8.34E-01   84                114                 *7.73\*\**   5.44E-03
                                                                                                                                               
  Sum                  928                 928                                              928               928                              

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

###### 

Spectrum of mutations in β-strands in amino acid groups^a^

  Amino acid group     Original residues   Expected residues   χ^2^              *P*value   Mutant residues   Expected residues   χ^2^           *P*value
  -------------------- ------------------- ------------------- ----------------- ---------- ----------------- ------------------- -------------- ----------
  Hydrophobic          241                 285                 *6.72\*\**        9.54E-03   170               191                 2.27           1.32E-01
  Positively charged   38                  40                  0.12              7.31E-01   46                42                  0.36           5.47E-01
  Negatively charged   113                 65                  **35.48\*\*\***   2.58E-09   115               90                  **7.07\*\***   7.82E-03
  Conformational       59                  39                  **10.86\*\*\***   9.81E-04   74                66                  0.98           3.21E-01
  Polar                44                  53                  1.62              2.03E-01   95                94                  0.01           9.18E-01
  A+T                  55                  68                  2.58              1.08E-01   50                67                  *4.47\**       3.45E-02
                                                                                                                                                 
  Sum                  550                 550                                              550               550                                

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

###### 

Spectrum of mutations in turns and bends in amino acid groups^a^

  Amino acid group     Original residues   Expected residues   χ^2^              *P*value   Mutant residues   Expected residues   χ^2^           *P*value
  -------------------- ------------------- ------------------- ----------------- ---------- ----------------- ------------------- -------------- ----------
  Hydrophobic          80                  105                 *6.02\*\**        1.42E-02   151               160                 0.50           4.80E-01
  Positively charged   44                  62                  *5.21\**          2.24E-02   52                35                  **7.92\*\***   4.88E-03
  Negatively charged   96                  68                  **11.94\*\*\***   5.48E-04   98                75                  **6.87\*\***   8.78E-03
  Conformational       152                 102                 **24.95\*\*\***   5.90E-07   55                55                  0.00           9.71E-01
  Polar                53                  81                  *9.44\*\**        2.12E-03   62                79                  3.58           5.85E-02
  A+T                  36                  44                  1.48              2.24E-01   43                56                  3.20           7.34E-02
                                                                                                                                                 
  Sum                  461                 461                                              461               461                                

^a^χ^2^-numbers in italics indicate underrepresentation and numbers in bold overrepresentation compared to random distribution based on amino acid frequencies. The results of the χ^2^are shown with significance level: \* *P*\< 0.05; \*\* *P*\< 0.01; \*\*\* *P*\< 0.001.

Mutations to polar residues are significantly depleted in α-helices and especially so in turns and bends. The number of significant observations is lower in mutant residues. Negatively charged amino acids are overrepresented in both β-structures and in bends and turns, although the enrichment is relatively weak. Alanine and threonine are underrepresented in both helices and β-strands. These results likely reflect the importance of the original residue. Many disease-causing mutations affect the same positions indicating that the site is structurally or functionally important, where any mutation disrupts the protein activity.

Changes in amino acid volume and charge due to mutations
--------------------------------------------------------

Next we examined the differences in volume and charge between the original residue and the replacing mutant residue (Fig. [2](#F2){ref-type="fig"}). The replacing residues within α-helices and β-strand structures are generally physically smaller than the original residues while in turns and bends the volume is remarkably increased. In 3~10~-helices the replacing residue is on average 13.5 Å^3^smaller than the original residue and in α-helices almost 4 Å^3^smaller. Mutations to residues in β-bridges increase the volume, while mutations in β-strands on average reduce the volume of the amino acid. The increase in volume in turns is 22.6 Å^3^and in bends 15.8 Å^3^, thus on average the replacing residue is much larger than the original residue. In turns and bends, glycines form the biggest group among mutated native amino acids. Because glycine is the smallest amino acid, all mutations in G increase the volume of the protein. Differences at the amino acid level show that there are clear peaks in some residues, and that the changes in all secondary structure types are very similar (Fig. [3](#F3){ref-type="fig"}). Glycine (68 Å^3^) is replaced by residues that are on average 85 Å^3^larger in turns and bends, 83 Å^3^larger in α-helices and 78 Å^3^larger in β-strands. The largest residues are W, Y, F and R. The largest amino acid, tryptophan (237 Å^3^) is replaced by residues whose volume is on average 100 Å^3^smaller in β-strands and 94 Å^3^and 93 Å^3^smaller in α-helices and turns and bends, respectively. Being a bulky residue, tryptophan is very rare in turns and bends. In our dataset W accounted for 1% of all residues in turns and bends. There was just one mutated W in bends and three in turns.

![**Changes to properties of amino acids caused by mutations**. Average changes per residue in residue volumes when comparing original amino acid and mutated amino acid in A) α-helices, β-strands, turns and bends and B) separately in α-helices (H), 3~10~-helices (G), extended strands (E), isolated β-bridges (B), turns (T) and bends (S). C) Average changes per residue in charges when comparing original amino acid and mutated amino acid in α-helices, β-strands, turns and bends and D) separately in α-helices, 3~10~-helices, extended strands, isolated β-bridges, turns and bends.](1472-6807-7-56-2){#F2}

![**Changes in mutations to residue volumes**. Average changes in mutations to residue volumes in α-helices (red), β-strands (blue), turns and bends (green). The thick line indicates the original amino acid volumes. Outer rings indicate addition in volume and inner rings reduction, in steps of 35 Å^3^.](1472-6807-7-56-3){#F3}

Average changes in isoelectric point (IEP) are similar for the main secondary structure types (Fig. [2C](#F2){ref-type="fig"}). In all the structures the IEP is increased on average compared to the normal structure. There are differences in the extent of the change, the largest changes are in turns and bends -- on average close to 0.8 pI. The reason for the dramatic average increase in pI values is the introduction of prolines and lysines that have relatively high pI values. Arginine has the highest pI value of all amino acids, but in turns and bends there is almost equally high enrichments of arginines both in mutated and mutant residues, so arginines do not affect IEP crucially. Figure [2D](#F2){ref-type="fig"} also shows in detail the changes in different helices and β-structures. The change is much larger in 3~10~-helices than in α-helices. A similar situation is seen for bends in which mutations lead to clearly larger changes. Differences at the amino acid level show that changes in charge in α-helices and β-strand structures are minor but in turns and bends there are clear peaks in some of the residues. C and E are replaced by residues with lower pI values and basic K and R by residues with higher pI values (Fig. [4](#F4){ref-type="fig"}).

![**Changes in mutations to residue charges**. Average changes in mutations to residue charges in α-helices (red), β-strands (blue), turns and bends (green). The thick line indicates the original amino acid charges. Outer rings indicate higher charge values and inner rings lower, in steps of 1.25 pI.](1472-6807-7-56-4){#F4}

The role of contact energies
----------------------------

We used RankViaContact \[[@B46]\] to calculate residue contact energies for all proteins in the dataset based on three-dimensional structures. The contact energies of the mutated residues range from very strong -27.6 to 7.8. The mutations are ranked based on their calculated contact energies. A slight majority (55%) of the mutations have strong or very strong contact energies. Most residues with strong contact energies are important for the stability of the protein structure. Many of the disease-related mutations are thus located in crucial structural sites in which alterations are deleterious. In figure [5A](#F5){ref-type="fig"} the count of contact energies of the mutated residues has been calculated in all proteins and separately for secondary structures. In β-strand the distribution of contact energies are even, but in other structures the distribution is biased towards weak positive contact energies.

![**Distribution of contact energies for mutated amino acids**. The energies were calculated with the RankViaContact program. A) Data for all mutations, and B) distribution in secondary structural elements α-helices (red), β-strands (blue), turns and bends (green), outside secondary structures (yellow), and whole proteins (black).](1472-6807-7-56-5){#F5}

Figure [5B](#F5){ref-type="fig"} shows the contact energy distribution for mutations in proteins and secondary structure types as well as outside the secondary structural elements. The curves have quite similar overall shapes although the location of the peak for the maximal occurrence varies. Of note is also that the mutation positions in turns and bends and outside secondary structures do not appear in sites of very strong contacts. Mutation sites in β-structures have very even distribution throughout the contact energy range.

We organized the residues into six groups based on their physicochemical properties and calculated the percentages of strong and weak contact energies in the groups (Fig. [6](#F6){ref-type="fig"}). Among hydrophobic residues more than 90% of the original amino acids have strong contact energies. Polar, conformational, positively and negatively charged mutated residues have for the most part weak contact energies (70--85%). A and T residues have mainly strong contact energies. These results indicate the importance of the residue type for interactions -- whether hydrophobic, van der Waals or electronic interactions. Charged residues often form salt bridges, while hydrophobic and aliphatic amino acids are involved in weaker interactions. A large proportion of mutated residues are forming interactions which are essential for the protein and its structure. Structural alterations are the most common consequence of disease-causing mutations \[[@B18]\].

![**Mutant residues with strong and weak contact energies**. The percentage of mutant residues with strong (black) and weak (white) contact energies in physicochemical amino acid groups.](1472-6807-7-56-6){#F6}

Conclusion
==========

Germline substitutions leading to the replacement of a native residue can result in either benign effects (e.g. polymorphisms) or in genetic disease. It has been shown that most positions in proteins can be altered without serious effects on protein structure or function \[[@B47]\]. On the other hand, the majority of disease-causing mutations have structural effects \[[@B14]\]. Therefore, mutations that are phenotypic for disease indicate the importance for the specific location. Knowledge of the molecular basis of mutations is important and can be used in several ways.

Mutation spectra are clearly different for the different structural elements. The most prominent feature for all the elements is the strong overrepresentation of arginine as mutated residue. Large changes in the properties of mutant amino acids, in volume or charge, are disease-related, but there are large differences for the structural elements. Contact energy distributions of mutated residues are surprisingly similar except for β structures. About half of the mutation sites are involved in strong or very strong amino acid interactions. In conclusion, there are many and strong trends in mutant and mutated residues. The trends are statistically significantly different for the different secondary structures.

Previously, mutation statistics have been studied at a general level \[[@B8],[@B12],[@B48]\] as well as a structural level \[[@B9],[@B12]\], but detailed analysis of the spectrum and effects of mutations within secondary structural elements has been missing. In the study of Ferrer-Costa et al. \[[@B12]\] the dataset consisted of 1169 disease-associated single amino acid polymorphisms (daSAPs) distributed over 73 proteins with structure information from the PDB. The study combines information from all secondary structure elements without element specific data. In the study of Steward and co-workers \[[@B9]\] 63 proteins contained 1292 disease-associated sites. They did not analyse secondary structures separately. Our study involved 1939 missense mutations in secondary structures and 2411 mutations altogether. We localized the majority of missense mutations to α-helices. The biggest group of daSAPs is found in coils, and helices contain 36.7% of all daSAPs. Ferrer-Costa et al. also included volume comparisons in their study. In contrast to our work, the size changes to daSAPs were calculated for the whole dataset. We calculated the changes for each secondary structure type separately, also at amino acid level. Arginine is the most commonly mutated residue. The result is identical to Steward et al \[[@B9]\]. Wang and Moult \[[@B18]\] examined 262 missense mutations in 23 proteins and concluded that 80% of mutations destabilize the protein structure relative to the folded state based on changes in hydrophobic burial, backbone strain, overpacking, and electrostatic interactions. In several other studies, structural properties have been combined with a sequence profile for the mutated position \[[@B21],[@B23],[@B49]\], which reflects the occurrence of other amino acid types at corresponding sites in homologous proteins.

Vitkup et al. \[[@B11]\] investigated in total, 4236 mutations from 436 genes and concluded that mutations at arginine and glycine residues are together responsible for about 30% of genetic diseases. This result is similar to ours. In our dataset, 25% of all missense mutations occur in R and G, and 23% are present in the examined secondary structures. Vitkup et al. also found that random mutations at tryptophan and cysteine have the highest probability of causing disease, which is in line with our results. The overall relative mutability to mutant residues is 3.46 for C and 3.31 for W compared to alanine which has the lowest ratio of observed vs. expected mutations and is considered as 1.

To correlate the mutated and mutant types to protein structures it is important to know at which secondary structural element the alteration appears. Protein function and interactions require both stability and specificity. Proteins fold according to the minimum free energy. In contrast, they organize themselves to recognize a transition state or a ligand \[[@B50]\]. Amino acids and mutations have very distinct differences in the frequencies in the secondary structural elements. Multiple sequence alignments can be used to investigate allowed substitutions in protein families. Our analysis revealed mutation types which are most likely deleterious. This information could also be used for the development and optimization of amino acid comparison tables for individual secondary structural elements. Our data could also add to the reliability of the predictions of mutation effects.

Methods
=======

We investigated proteins for which numerous disease-causing missense mutations were available along with an experimentally defined three-dimensional structure. Mutation data was collected from BTKbase \[[@B51]-[@B53]\] for Btk mutations, CD40Lbase \[[@B54]-[@B56]\] for CD40L mutations and from Human Gene Mutation Database (HGMD) \[[@B6]\] for the remainder. The publicly available mutations are in the supplementary table [4](#T4){ref-type="table"} \[see Additional file [4](#S4){ref-type="supplementary-material"}\], full list is available from authors by request. The DSSP program \[[@B57]\] was used to identify secondary structures for three helix types, two extended β-strand types, turns and bends, based on the stereochemistry of the protein structure. The DSSP program was used to systematically assign secondary structures for each residue in the three-dimensional structures obtained from the Protein Data Bank (PDB) \[[@B58]\]. A Perl script was written to connect mutation information to protein structure data (dssp files).

If more than one structure existed for a protein or a protein domain, the one with the highest resolution and the longest chain length was chosen. All data was stored in a mySQL database. Altogether we investigated 44 proteins with a total of 12540 residues, of which 9878 were in the examined secondary structures. The proteins contained 2411 different disease-causing mutations, 1939 present in secondary structures.

The RankViaContact service was used to calculate residue-residue contact energies based on a coarse-grained model \[[@B46]\]. The energy parameters used for residue-residue contacts \[[@B59]\] were derived considering the secondary structural environments. The contact energies were estimated for all the missense mutations located in the secondary structures.

Mutation statistics were analysed by comparing the frequencies of the obtained mutations with the expected values. Expected values for mutated residues within α-helices, β-strands and turns and bends were calculated using the distribution of all amino acids in respective secondary structure. In the case of the mutant amino acids within different secondary structures, the expected values were calculated from codon diversity by taking into account all possible amino acid substitutions. In order to reveal how the mutation distribution in secondary structures compares to the overall distribution of mutations in the dataset, the expectation values for mutated and mutant residues were calculated based on all the mutations in secondary structures.

The χ^2^test was used to determine the significance of the results. Chi square values were calculated using the following formula:

$$\chi^{2} = \Sigma\frac{{(f_{o} - f_{e})}^{2,}}{f_{e}}$$

where *f*~*o*~is the observed frequency and *f*~*e*~is the expected frequency for an amino acid. *P*-values and 95% confidence intervals were estimated in one-tailed fashion. Relative mutability was calculated using the formula:

$$Rm(N) = \frac{(N_{obs} \cdot {N^{\prime}}_{exp})}{({N^{\prime}}_{obs} \cdot N_{exp})},$$

where *N\'*is the least mutated residue type that was obtained by calculating the ratio between observed and expected value. *N*represents the number of mutated original or mutant residues for an amino acid type. The relative mutability was calculated for each residue type in all the investigated secondary structural elements.

In order to calculate changes in the isoelectric point we used the Emboss iep program \[[@B60]\] to predict IEPs for native and mutant proteins. The average change in IEP in each secondary structure type was calculated. The changes in residue volumes in different secondary structure types were obtained by using residue volumes \[[@B61]\]. The results were weighted by the amount of individual mutations and averaged by the number of mutant residues in respective secondary structures.
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